Esperion Therapeutics Added to the NASDAQ Biotechnology Index by longitudeadmin | Dec 23, 2013 | Portfolio News
UPDATE 2-Jazz Pharma to buy Italy’s Gentium for $1 bln by longitudeadmin | Dec 19, 2013 | Portfolio News
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share by longitudeadmin | Dec 19, 2013 | Portfolio News
Corcept Therapeutics Announces Oncology Development Program by longitudeadmin | Dec 12, 2013 | Portfolio News
Practice Fusion Raises Additional $15M to Close Year of Exponential Platform Growth by longitudeadmin | Dec 9, 2013 | Portfolio News
